American Heart Association Basic Cardiovascular Sciences OnDemand 2026

The American Heart Association (AHA) Basic Cardiovascular Sciences (BCVS) Scientific Sessions 2026 is one of the largest meetings globally dedicated to fundamental and translational research in cardiovascular science. Scheduled to take place from July 13–16, 2026, at the Sheraton Boston in Boston, Massachusetts, this conference is a unique and career-essential event. It serves as a premier platform for international ideation and the development of new therapeutics for the treatment and management of cardiovascular diseases.
Learning Objectives

Participate in the international ideation and development of new therapeutics for the treatment and management of cardiovascular diseases.

Understand the latest mechanisms in cardiac cellular signaling, cross-talk, and myocardial hypertrophy and remodeling.

Explore advancements in cardiac repair, biomaterials, and tissue engineering.

Examine the impact of cardio-immunology and inflammation on heart health.

Analyze cardiovascular development, gene regulation, and the origins of congenital heart disease.

Identify molecular targets for heart failure, cardiomyopathy, and cardiovascular fibrosis.

Evaluate new mechanisms in cardiac arrhythmia and systemic metabolic axes beyond the heart.

Target Audience
Engage with leading researchers in fields like microRNAs, cardiac gene and cell therapy, cardiac development, tissue engineering, and iPS cells. Network with a multitude of colleagues at the conference known for playing a pivotal role in training young and diverse researchers.
Best for Cardiologists, Cardiovascular Surgeons, Immunologists, Geneticists, Endocrinologists, Electrophysiologists, and Biomedical Engineers.
Topics

BCVS 2026 Closing Remarks

BCVS 2026 Keynote Lecture

Cardiac Cellular Signaling Mechanisms and Cross talk

Cardiac Growth Hypertrophy and Remodeling

Cardiac Repair Biomaterials and Tissue Engineering

Cardiac Sarcomeres and Myofilaments

Cardio-Immunology Inflammation Immunity and the Heart

Cardiovascular Development Gene Regulation and Congenital Heart Disease

Early Career Keynote

Early Career Pre-Conference Opening Welcome

Early Career Pre-Conference Session 1 Next Best Thing

Early Career Pre-Conference Session 2 Next Best Thing

Emerging Cardiovascular Translational Technologies

Molecular Targets for Heart Failure and Cardiomyopathy

Outstanding Early Career Investigator Award

Pathophysiologic and Systemic Axes Beyond the Heart

The Age of Metabolism

Unlocking New Mechanisms in Cardiac Arrhythmia

Whats New in Cardiovascular Fibrosis